Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -69.35% | 14.63% | -69.70% | -29.92% | 16.98% |
| Total Other Revenue | 0.00% | 0.00% | 0.00% | -8.33% | 120.00% |
| Total Revenue | -63.70% | 13.43% | -64.34% | -28.91% | 21.62% |
| Cost of Revenue | -1.63% | 71.11% | 0.00% | -35.87% | 0.82% |
| Gross Profit | -700.00% | -104.55% | -209.09% | -11.11% | 209.09% |
| SG&A Expenses | 13.71% | 33.46% | 29.78% | -4.36% | -8.39% |
| Depreciation & Amortization | -- | -62.50% | -78.13% | -81.58% | -82.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.33% | 36.93% | 31.37% | -0.66% | -9.44% |
| Operating Income | -17.42% | -38.33% | -35.94% | -1.58% | 10.34% |
| Income Before Tax | -52.54% | -275.89% | -0.63% | 2.18% | -0.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.54% | -275.89% | -0.63% | 2.18% | -0.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.54% | -275.89% | -0.63% | 2.18% | -0.88% |
| EBIT | -17.42% | -38.33% | -35.94% | -1.58% | 10.34% |
| EBITDA | -17.74% | -39.10% | -37.33% | -2.62% | 9.55% |
| EPS Basic | 83.50% | 28.93% | 82.03% | 78.07% | 30.37% |
| Normalized Basic EPS | 83.50% | 29.66% | 81.22% | 78.07% | 30.37% |
| EPS Diluted | 83.44% | 28.95% | 81.97% | 78.08% | 30.33% |
| Normalized Diluted EPS | 83.50% | 29.66% | 81.22% | 78.07% | 30.37% |
| Average Basic Shares Outstanding | 824.40% | 429.45% | 460.45% | 346.54% | 44.95% |
| Average Diluted Shares Outstanding | 824.40% | 429.45% | 460.45% | 346.54% | 44.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |